Show simple item record

dc.contributor.authorRoche, James J.
dc.date.accessioned2019-10-24T08:02:40Z
dc.date.available2019-10-24T08:02:40Z
dc.date.copyright2008
dc.date.issued2008-04
dc.identifier.citationRoche, J.J. (2008). Advanced therapies and the outer limits of DNA regulation: new horizons for patents or a scaffold too far? Journal of Intellectual Property Law & Practice. 3 (4), 210-212en_US
dc.identifier.issn1747-1532
dc.identifier.otherArticles - Life and Physical Sciences AITen_US
dc.identifier.urihttp://research.thea.ie/handle/20.500.12065/2838
dc.description.abstractThis Regulation seeks to regulate existing and future advanced therapy medicinal products intended for the market in Member States, being either prepared industrially or manufactured by a method involving an industrial process, and introduces additional provisions to those laid down in the pharmaceutical legislation Directive 2001/83.en_US
dc.formatPDFen_US
dc.language.isoenen_US
dc.publisherOxford Academicen_US
dc.relation.ispartofJournal of Intellectual Property Law & Practiceen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/ie/*
dc.subjectDrugs - Law and Legislationen_US
dc.titleAdvanced therapies and the outer limits of DNA regulation: new horizons for patents or a scaffold too far?en_US
dc.typeArticleen_US
dc.description.peerreviewyesen_US
dc.identifier.doihttps://doi.org/10.1093/jiplp/jpn019
dc.identifier.orcidhttps://orcid.org/0000-0003-2995-3000
dc.rights.accessOpen Accessen_US
dc.subject.departmentFaculty of Science and Healthen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland